PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,493 stories, page 595 of 742

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Abivax stock surges on obefazimod safety data, cancer concerns

qz.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pune: FDA Shuts Down Mathura Pure Veg Temporarily Over Food Safety Violations

Punekar NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Glenmark Pharma jumps over 2% on launch of Olanzapine single-dose vial

Business StandardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lotte chairman declares biotech a new core business

매일경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Draft for Comments || Amendment to FDA Circular No. 2025-001 entitled “Guidelines on the Classification of Vitamins and Minerals for Food/Dietary Supplements for Adults under Processed Food Product, Repealing the Level Set for Food in the Office Order N

fda.gov.phOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mah FDA warns against 3 beauty creams after tests detect excessive mercury, lead

thehitavada.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Black Diamond Therapeutics: Positive Phase 2 Results Offer An Upside (NASDAQ:BDTX)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What NPPA's Renewed Focus on Form III Reporting Means for Pharmaceutical Companies

ETPharma.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Aussie super funds hit the jackpot in $2b UK biotech deal

AFROriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cash per share of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Will These Upcoming Milestones Re-rate The Stock?

MoomooOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China, HK stocks gain as AI enthusiasm broadens to farming, biotech sectors

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Positive Phase 2 Results for New Oral GLP-1 for Obesity

MedscapeOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Opinion: The FDA must put biotech at its center or continue to cede early research to China

BioSpaceOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Despite chaos and churn, FDA decisions hold mostly steady in H1 2026

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Triple-Digit Gains Haven’t Killed This Biotech’s Upside. Here’s What Comes Next

NAI500Original source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Convenience Kit Correction: Windstone Medical Packaging, Inc. Issues Correction for Convenience Kit

Certain Cardinal Health Webcol Large Alcohol Prep Pads in Custom Convenience Kits manufactured by Al...

FDA MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (TSE:4502) Is Up 5.3% After New Insilico AI Drug Discovery Deal - Has The Bull Case Changed?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ETFs Investing in Takeda Pharmaceutical Co. Ltd. Sponsored ADR Stocks

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bulgaria moves to shore up generic medicines access amid shortage crisis

EuractivOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Startup Island TAIWAN Bridges Tech Hubs, Launching East Coast Biotech Initiative in Boston

PR NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines Is Up Nearly 140% in 2026. Is the Hot Biotech Stock Still a Buy?

The Motley FoolOriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Regeneron filed Form 8-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Novo Nordisk filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

AbbVie filed Form 8-K

SEC EDGAROriginal source
🇿🇦Researchnews.uct.ac.zaTier 2 · Direct publisher

‘Constitutional democracies are under stress’

University of Cape TownOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications

The Food and Drug Administration (FDA or Agency) is withdrawing approval of 34 new drug applications...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I; Request for Information

The Office of the Assistant Secretary for Health (OASH or we) is opening a public docket to solicit...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Patient Safety Organizations: Voluntary Relinquishment for the Cassatt Patient Safety Organization

The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule) authorizes AHRQ, on beha...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Po

This proposed rule would set forth routine updates to the Medicare home health payment rates in acco...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Expedited Investigational New Drug Pilot Program; Request for Information; Correction

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Proposed Collection; 60-day Comment Request; Generic Clearance for NIH Citizen Science and Crowdsourcing Projects (Office of the Director)

In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Privacy Act of 1974; Matching Program

In accordance with subsection (e)(12) of the Privacy Act of 1974, as amended, the Department of Heal...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Proposed Data Collection Submitted for Public Comment and Recommendations

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce pub...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Forms Undergoing Paperwork Reduction Act Review

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Practices and Procedures; Formal Hearings

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has b...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Proposed Collection; Comment Request; Biologics License Applications, Procedures and Requirements

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Approval of Medical Devices

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has b...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The Food and Drug Administration (FDA or Agency) has determined that VASOPRESSIN IN SODIUM CHLORIDE...

Federal RegisterOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: RIVAROXABAN

Official structured record identifier: 481b7802-5093-43e7-bbd9-1532197eb6e6.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Calmco Allergy Relief

Official structured record identifier: 471b1a43-1708-8be7-e063-6394a90a9bb7.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Duloxetine

Official structured record identifier: 461d769c-b787-4bc7-b4a6-7a5f33ae9d45.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ibuprofen

Official structured record identifier: 421156d2-85dc-4680-b2b4-d15b67539e87.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Deflazacort

Official structured record identifier: 40818600-3ff0-4c9c-8e31-2001425a7dc9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Prazosin Hydrochloride

Official structured record identifier: 39e3fa5d-ea48-4b02-80f6-44591f5e013f.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Lisinopril

Official structured record identifier: 34953f77-bae1-41fe-af11-3ea0b3ceaa11.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Carvedilol

Official structured record identifier: 32098c09-7580-4975-a3e1-31b619c04c69.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Sucralfate

Official structured record identifier: 30c0965a-02a0-46b5-aa09-3f5fb5047b22.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Dr Kids Pain and Fever

Official structured record identifier: 2ee6df99-727a-34c6-e063-6294a90a6bbc.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Estradiol valerate

Official structured record identifier: 2e5c7559-7420-168d-6272-92bb4d20035d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Methimazole

Official structured record identifier: 2c6a9c70-4ed6-4f05-bc3d-e8e7aca57c2b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Dr Kids Allergy Relief

Official structured record identifier: 28ec213e-fabb-28ec-e063-6394a90ad102.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Paroxetine

Official structured record identifier: 28ddc9e0-05c5-482f-9371-60bbee451b33.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Levetiracetam

Official structured record identifier: 266d4ead-fda2-f030-e063-6394a90a68e2.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Aspirin

Official structured record identifier: 227cefca-acc4-41d0-e063-6394a90a35b9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: HGH Plus

Official structured record identifier: 20542ed4-eece-437c-a88f-ccd666afce03.

openFDA Drug LabelsOriginal source